Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2005-05-10
2005-05-10
Harris, Alana M. (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S300000, C530S350000, C530S385000, C530S386000, C530S387100, C530S387200, C530S387300, C530S387700, C530S387900, C530S388100, C530S388200, C530S388800, C530S388850, C530S391100, C530S391300, C435S325000
Reexamination Certificate
active
06891022
ABSTRACT:
The present invention relates to nucleotide sequences, including expressed sequence tags (ESTs), oligonucleotide probes, polypeptides, antagonists and agonists vectors and host cells expressing, and immunoadhesions and antibodies to PRO201, PRO308 or PRO309 polypeptides. The invention further relates to compositions and method for the diagnosis and treatment of neoplastic cell growth and proliferation in mammals, including humans. The invention is based in part on the identification of genes that are amplified in the genome of tumor cells. Such gene amplification is expected to be associated with the overexpression of the gene product and contribute to tumorigenesis. Accordingly, the proteins encoded by the amplified genes are believed to be useful targents for the diagnosis and/or treatment (including prevention) of certain tumors (e.g., cancer) and may act as predictors of the prognosis of tumor treatment.
REFERENCES:
patent: 4543439 (1985-09-01), Frackelton, Jr. et al.
patent: 4544545 (1985-10-01), Ryan et al.
patent: 5120525 (1992-06-01), Goldenberg et al.
patent: WO 9806841 (1998-02-01), None
patent: WO 9906831 (1999-02-01), None
Roitt et al. 1993. Mosby. Immunology, third edition. pp. 6.4 and 6.5.*
Staerz, Uwe D. and Bevan, Michael J. Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity, Proc. Natl. Acad. USA 83:1453-1457, 1986.*
Schulte, Roberta J. et al. Tyrosine Phosphorylation of VCP, the Mammalian Homologue of theSaccharomyces cerevisiaeCDC48 Protein, Is Unusually Sensitive to Stimulation by Sodium Vanadate and Hydrogen Peroxide, The Journal of Immunology 153:5465-5472, 1994.*
van Agthoven, Ton et al. Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells. The EMBO Journal 17(10):2799-2808, 1998.*
Amino acid database, Accession #O75815, 1998.*
Staerz, Uwe D. and Bevan, Michael J. Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity, Proc. Natl. Acad. USA 83:1453-1457, 1986.*
Bird, Robert E. et al. Single-Chain Antigen-Binding Proteins, Science 242:423-426, 1988.*
Araki et al., “Human skeletal muscle insulin receptor substrate-1. Characterization of the cDNA, gene, and chromosomal localization”Diabetes42(7):1041-1054 (Jul 1993).
Blast Results A-1—A-3 (GenBank).
Casamassima and Rozengurt, “Tyrosine phosphorylation of p130casby bombesin, lysophosphatidic acid, phorbol esters, and platelet-derived growth factor. Signaling pathways and formation of a p130cas-Crk complex”Journal of Biological Chemistry272(14):9363-9370 (Apr 4, 1997).
Chen et al., “Osmotic shock stimulates GLUT4 translocation in 3T3L1 adipocytes by a novel tyrosine kinase pathway”Journal of Biological Chemistry272(43):27401-27410 (Oct 24, 1997).
Daniel and Reynolds, “The tyrosine kinase substrate p120casbinds directly to E-cadherin but not to the adenomatous polyposis coli protein or α-catenin”Molecular&Cellular Biology15(9):4819-4824 (Sep 1995).
Doerr and Jones, “The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells”Journal of Biological Chemistry271(5):2443-2447 (Feb 2, 1996).
Frantz et al., “Human GRB-IRβ/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains”Journal of Biological Chemistry272(5):2659-2667 (Jan 31, 1997).
Hotamisligil et al., “Tumor necrosis factor α inhibits signaling from the insulin receptor”Proc. Natl. Acad. Sci. USA91(11):4854-4858 (May 24, 1994).
Jones et al., “Ligand occupancy of the αVβ3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor I”Proc. Natl. Acad. Sci. USA93(6):2482-2487 (Mar 19, 1996).
Kanety et al., “Tumor necrosis factor α-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1”Journal of Biological Chemistry270(40):23780-23784 (Oct 6, 1995).
Knight et al., “Divergent insulin and platelet-derived growth factor regulation of focal adhesion kinase (pp125FAK) tyrosine phosphorylation, and rearrangement of actin stress fibers”Journal of Biological Chemistry270(17):10199-10203 (Apr 28, 1995).
Kulik et al., “Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt”Molecular&Cellular Biology17(3):1595-1606 (Mar 1997).
Leventhal et al., “Tyrosine phosphorylation of paxillin and focal adhesion kinase during insulin-like growth factor-I-stimulated lamellipodial advance”Journal of Biological Chemistry272(8):5214-5218 (Feb 21, 1997).
Liu and Roth, “Grb-IR: a SH2-domain-containing protein that binds to the insulin receptor and inhibits its function”Proc. Natl. Acad. Sci. USA92(22):10287-10291 (Oct 24, 1995).
Luttrell et al., “Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation”Journal of Biological Chemistry272(7):4637-4644 (Feb 14, 1997).
Matsumoto et al., “Growth factor regulation of integrin-mediated cell motility”Cancer and Metastasis Reviews14(3):205-217 (Sep 1995).
Mo and Reynolds, “Identification of murine p120casisoforms and heterogeneous expression of p120casisoforms in human tumor cell lines”Cancer Research56(11):2633-2640 (Jun 1, 1996).
Nakamoto et al., “Requirements for localization of p130casto focal adhesions”Molecular&Cellular Biology17(7):3884-3897 (Jul 1997).
Nakamura et al., “N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway”Oncogene13(6):1111-1121 (Sep 19, 1996).
Nojima et al., “Integrin-mediated cell adhesion promotes tyrosine phosphorylation of p130Cas, a Src homology 3-containing molecule having multiple Src homology 2-binding motifs”Journal of Biological Chemistry270(25):15398-15402 (Jun 23, 1995).
Ojaniemi and Vuori, “Epidermal growth factor modulates tyrosine phosphorylation of p130Cas. Involvement of phosphatidylinositol 3′-kinase and actin cytoskeleton”Journal of Biological Chemistry272(41):25993-25998 (Oct 10, 1997).
Parrizas et al., “Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways”Journal of Biological Chemistry272(1):154-161 (Jan 3, 1997).
Pawson and Scott, “Signaling through scaffold, anchoring, and adaptor proteins”Science278(5346):2075-2080 (Dec 19, 1997).
Polte and Hanks, “Interaction between focal adhesion kinase and Crk-associated tyrosine kinase substrate p130Cas”Proc. Natl. Acad. Sci. USA92(23):10678-10682 (Nov 7, 1995).
Sakai et al., “A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner”EMBO Journal13(16):3748-3756 (Aug 15, 1994).
Sakai et al., “Characterization of the kinase activity essential for tyrosine phosphorylation of p130Casin fibroblasts”Oncogene14(12):1419-1426 (Mar 27, 1997).
Vemuri and McMorris, “Oligodendrocytes and their precursors require phosphatidylinositol 3-kinase signaling for survival”Development122(8):2529-2537 (Aug 1996).
Hillier et al., “aa13a07.r1 Soares NhHMPu S1 Homo sapeins cDNA clone 813108 5′” (Database EMBL—EMEST11 Online Accession No. AA456485) (Jun 7, 1997).
Hillier et al., “z186b01.s1 Stratagene colon (#937204) Homo sapiens cDNA clone 511465 3′” (Database EMBL EMEST15 Online Accession No. AA126234) (Nov 30, 1996).
Lu et al., “Nsp1 defines a member of a family of novel adaptor proteins linking RTK an
Lu Yanmei
Stewart Timothy A.
Genentech Inc.
Harris Alana M.
Sidley Austin Brown & Wood LLP
LandOfFree
NSP molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NSP molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NSP molecules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3391107